Skan Group Ag · SIX:SKAN
Skan — H1 2025 Earnings Presentation
27 slides from Skan's earnings presentation, Aug 19, 2025
Slide 1: Presentation of the HY 2025 Financial Results
SKAN Group AG Presentation of the HY 2025 Financial Results 19 August 2025
Slide 2: Disclaimer
SKAN Disclaimer THIS PRESENTATION AND ITS CONTENTS ARE CONFIDENTIAL AND ARE NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN OR INTO OR FROM THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA, JAPAN OR ANY JURISDICTION WHERE SUCH DISTRIBUTION IS UNLAWFUL. Th
Slide 3: Agenda
SKAN Agenda 1. Overview of HY 2025 Thomas Huber (CEO) 2. 3. 4. 19 August 2025 SKAN Group AG Presentation of the HY 2025 Financial Results 3
Slide 4: Highlights of the first half year
SKAN Highlights of the first half year SKAN recorded strong order intake in the first half year. Order Intake Net Sales in CHF million in CHF million Order backlog climbed to a new record high and book-to-bill ratio at 213.0 134.6 1.6 provides good visibility. +20.2%(1) -17.8%(1) Net sales and EBITD
Slide 5: Both segments drive strategic initiatives forward
SKAN Both segments drive strategic initiatives forward Equipment & Solutions Strong order intake in the first half of 2025 (+28.4%). Lower net sales and negative segment EBITDA due to project postponements and continued investments in strategic initiatives. R&D expenses (9.8% of sales) were mainly a
Slide 6: Stronger customer proximity through accelerated decentralization and expanded offering
SKAN Stronger customer proximity through accelerated decentralization and expanded offering Allschwil CH Headquarters / production Germany sites Okinawa JP 325 Engineering, sales, service, USA Production site 130 assembly, R&D, laboratories Belgium Sales, assembly, and life 63 cycle support Far East
Slide 7: Another step towards the «one-stop-shop» solution provider for our customers
Another step towards the «one-stop-shop» solution provider for our customers 19 August 2025 SKAN Group AG Presentation of the HY 2025 Financial Results
Slide 8: Extension of service offering for customers with immediate value contribution
SKAN Extension of service offering for customers with immediate value contribution Objectives: Continue growth track-record Increase recurring revenue base Expand profitability 1 2 Expand addressable market 3 Increase exposure to after- 4 Accelerate digital Fortify market leadership towards integrat
Slide 9: Metronik – a leading software provider and integrator
Metronik – a leading software provider and integrator SKAN for production processes in the life science industry Leading provider of software for the digitization, automation and control of production and building management processes. Modular, proprietary and web-based software for manufacturing op
Slide 10: Digital backbone of modern pharma production environments
SKAN Digital backbone of modern pharma production environments MePIS is a suite of modular software MePIS MES solutions that enable manufacturing Manufacturing Execution System companies to digitalize and optimize production processes and facility buildings, while achieving full data integrity and r
Slide 11: ABC Transfer – specialized in transfer systems for the aseptic filling of pharmaceuticals
ABC Transfer – specialized in transfer systems for the SKAN aseptic filling of pharmaceuticals Leading innovator in patented secure rapid transfer systems, enhancing efficiency in pharmaceutical production. Offers several types of registered products: sterile transfer ports, sterile transfer bags an
Slide 12: Transfer systems for sterile pharmaceutical manufacturing
SKAN Transfer systems for sterile pharmaceutical manufacturing 01 02 03 Alpha port Beta container Single-use beta bags Stainless steel port integrated into isolators Connects to alpha port Connects to alpha port Connects to beta containers or beta bags Ensures the safe transfer of Ensures the safe t
Slide 13: Agenda
SKAN Agenda 1. 2. Financial Results HY 2025 Burim Maraj (CFO) 3. 4. 19 August 2025 SKAN Group AG Presentation of the HY 2025 Financial Results 13
Slide 14: Strong order intake momentum in the reporting period
SKAN Strong order intake momentum in the reporting period Order intake Order intake by regions Comments (CHFm and ∆ in%) (CHFm and ∆ in%) Robust growth fueled by high demand for 1.3x 0.7x 1.1x 0.9x 1.6x ADC (Antibody Drug Conjugates) filling +40.8% lines. +20.2% 213.0 125.3 With a book-to-bill ratio
Slide 15: SKAN’s project business characterized by non-linearity of value creation and cash-in
SKAN’s project business characterized by non-linearity of SKAN value creation and cash-in General value creation structure Net sales and EBIT recognition is closely linked (in % per project milestone) to value creation based on project progress using EBIT realisation Value creation Cash-In the cost-
Slide 16: Record backlog drives growth outlook for H2 and beyond
SKAN Record backlog drives growth outlook for H2 and beyond Net sales Order backlog Comments (CHFm and ∆ in%) (CHFm and ∆ in%) Net sales decrease mainly driven by project postponements. Additionally, more projects in lower value -17.8% +21.4% creation phases weighed on net sales. 163.7 386.4 Adjuste
Slide 17: Growth target on track for H2 despite temporary margin dip
SKAN Growth target on track for H2 despite temporary margin dip Expenses EBITDA Comments (CHFm) (CHFm and margin in %) EBITDA declined to CHF 0.9m, resulting +31 +33 13.1% 0.7% in a margin of 0.7%, primarily driven by non-linearity of value creation of the project business. -6.8% -95.7% (-9.9) (-20.
Slide 18: Segment Equipment & Solutions (E&S)
SKAN Segment Equipment & Solutions (E&S) Order intake Net sales EBITDA Comments (CHFm) (CHFm and as of % of Group net sales) (CHFm and margin in %) 349.5 289.9 294.2 283.0 346.0 73.4% 67.4% Strong increase of +28.4% YoY 7.4% -10.0% in order intake reflecting strong demand. +28.4% Net sales & EBITDA
Slide 19: Segment Services & Consumables (S&C)
SKAN Segment Services & Consumables (S&C) Order intake Net sales EBITDA Comments (CHFm) (CHFm and as of % of Group net sales) (CHFm and margin in %) 33.8 40.4 26.6% 32.6% Stable order intake and net 28.9% 22.8% sales mainly due to high comparative basis from H1 2024: +0.5% +0.6% extraordinary perfor
Slide 20: Cash flow driven by non-linearity of projects
SKAN Cash flow driven by non-linearity of projects Cash flow Net-working-capital (NWC) Comments (CHFm) (CHFm and in %) Operating CF and the significantly negative NWC of CHF 25.3m reflect 0.2 the non-linear project business, with -0.8 lower work-in-progress and strong (-1.4%) order intake leading to
Slide 21: Strong balance sheet & finance structure
SKAN Strong balance sheet & finance structure Balance sheet as of 30th June 2025 Comments (CHFm) -0.8% -0.8% SKAN Group posts a net cash position of CHF 42.9 million as of 384.5 381.5 384.5 381.5 30th June 2025. As a result, the Cash and SKAN’s net liquidity remained stable. 53.7 52.9 cash equivalen
Slide 22: Agenda
SKAN Agenda 1. 2. 3. Outlook 2025 Thomas Huber (CEO) 4. 19 August 2025 SKAN Group AG Presentation of the HY 2025 Financial Results 22
Slide 23: Confident market and business outlook
SKAN Confident market and business outlook Market development Business development SKAN continues to operate in a structurally growing market. Even though the cyclical nature of the first half of the year, Main drivers are: which is typical for the business, was more pronounced than in The underlyin
Slide 24: Expanding the SKAN location in the US
SKAN Expanding the SKAN location in the US Stability With our global presence and focus on customer proximity, SKAN is well positioned to ensure stability and delivery reliability even under changing trade and customs regulations. Strategic relevance Current developments in US customs policy confirm
Slide 25: Financial targets and guidance confirmed
SKAN Financial targets and guidance confirmed 2025 Guidance (1) Confirmed Mid-term Targets 1 Group net sales growth Mid-teens Mid- to upper teens (2) av 2 Segment net sales growth E&S S&C E&S S&C Gradually increase profitability level to 3 EBITDA margin 14 - 16% upper teens in the mid-term. Potentia
Slide 26: Together always one step ahead!
Together always one step ahead!
Slide 27: Abbreviations and Definitions
SKAN Abbreviations and Definitions Alternative Financial Performance Measures (APM) EBITDA: Operating result (EBIT) plus depreciation, amortisation. Net working capital (NWC): Total current assets (excluding cash and cash equivalents) minus trade payables, advance payments from EBITDA margin: EBITDA